ResearcherNo recent work listed

Nicholas Osborne

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5113878744. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2019: 2 papers

Papers 2

Gastrin vaccine improves response to immune checkpoint antibody in murine pancreatic cancer by altering the tumor microenvironment. Co-author DOI 10.1007/s00262-019-02398-6 ↗
Vaccine against gastrin, a polyclonal antibody stimulator, decreases pancreatic cancer metastases. Co-author DOI 10.1152/ajpgi.00145.2019 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jill Palmer Smith · 2 shared papers, 2019 · strength 0.18
- Paper Gastrin vaccine improves response to immune checkpoint antibody in murine pancreatic cancer by altering the tumor micro… DOI 10.1007/s00262-019-02398-6 ↗
- Paper Vaccine against gastrin, a polyclonal antibody stimulator, decreases pancreatic cancer metastases. DOI 10.1152/ajpgi.00145.2019 ↗
Julian Burks · 1 shared paper, 2019 · strength 0.10
- Paper Gastrin vaccine improves response to immune checkpoint antibody in murine pancreatic cancer by altering the tumor micro… DOI 10.1007/s00262-019-02398-6 ↗
Sandeep Nadella · 1 shared paper, 2019 · strength 0.09
- Paper Vaccine against gastrin, a polyclonal antibody stimulator, decreases pancreatic cancer metastases. DOI 10.1152/ajpgi.00145.2019 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.